跳至主要内容
临床试验/CTRI/2021/12/039008
CTRI/2021/12/039008尚未招募2 期

Flunarizine versus propranolol in prophylaxis of pediatric migraine : an open labelled trial

Pandit BDSharma UHSRPGIMS ROHTAK0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children aged 7 to 14 years with migraine with a score of 11 to 139 on Pediatric migraine Disability Assessment Score(PedMIDAS) and a headache frequency of 4 or more days per month over a baseline period of 28 days.

排除标准

  • Children with either of the following conditions will be excluded
  • chronic liver disease,
  • chronic kidney disease,
  • hypertension (BP >95TH percentile for age, sex, and height; or 130/80 mm hg for age >13yr)
  • diabetes, (fasting plasma glucose 126 mg/dl or 2hr plasma glucose during OGTT 200 mg/dl)
  • Obesity (BMI >95th percentile for age and sex)

研究者

发起方
Pandit BDSharma UHSRPGIMS ROHTAK

相似试验